| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8649524 | Cardiovascular Revascularization Medicine | 2017 | 7 Pages |
Abstract
In women undergoing PCI, bivalirudin is associated with reduced risk of major bleeding and NACE compared with heparin especially when GPI is routinely used.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
Authors
Marwan Saad, Ramez Nairooz, Ahmed Rashed, Hesham K. Abdelaziz, Amgad Mentias, J. Dawn Abbott,